Sio Capital Management as of March 31, 2024
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 50 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Laboratory Corporation Of America Holdings Com New | 14.7 | $49M | 226k | 218.46 | |
| Insmed Com Par $.01 Put Option (INSM) | 11.0 | $37M | 1.4M | 27.13 | |
| Cigna Corp (CI) | 8.2 | $28M | 76k | 363.19 | |
| Globus Medical Cl A (GMED) | 6.3 | $21M | 393k | 53.64 | |
| Madrigal Pharmaceuticals (MDGL) | 4.1 | $14M | 51k | 267.04 | |
| GSK Sponsored Adr (GSK) | 3.4 | $11M | 263k | 42.87 | |
| Zimmer Holdings (ZBH) | 2.9 | $9.8M | 74k | 131.98 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 2.9 | $9.8M | 1.1M | 8.71 | |
| Medtronic SHS (MDT) | 2.7 | $9.2M | 105k | 87.15 | |
| Organon & Co Common Stock (OGN) | 2.7 | $9.0M | 479k | 18.80 | |
| Tyra Biosciences (TYRA) | 2.6 | $8.8M | 536k | 16.40 | |
| Embecta Corp Common Stock (EMBC) | 2.3 | $7.8M | 585k | 13.27 | |
| Teleflex Incorporated (TFX) | 2.3 | $7.7M | 34k | 226.17 | |
| Arcutis Biotherapeutics (ARQT) | 1.9 | $6.3M | 636k | 9.91 | |
| Bridgebio Pharma (BBIO) | 1.9 | $6.3M | 203k | 30.92 | |
| Humacyte (HUMA) | 1.9 | $6.2M | 2.0M | 3.11 | |
| Biosante Pharmaceuticals (ANIP) | 1.8 | $6.0M | 87k | 69.13 | |
| Astria Therapeutics (ATXS) | 1.7 | $5.8M | 410k | 14.07 | |
| Silverback Therapeutics (SPRY) | 1.6 | $5.5M | 536k | 10.22 | |
| Healthcare Services (HCSG) | 1.6 | $5.3M | 421k | 12.48 | |
| Apogee Therapeutics (APGE) | 1.5 | $5.2M | 78k | 66.45 | |
| Fusion Pharmaceuticals | 1.5 | $5.2M | 243k | 21.32 | |
| Erasca (ERAS) | 1.5 | $5.0M | 2.4M | 2.06 | |
| X4 Pharmaceuticals (XFOR) | 1.5 | $5.0M | 3.6M | 1.39 | |
| Nuvation Bio Com Cl A (NUVB) | 1.4 | $4.9M | 1.3M | 3.64 | |
| Scholar Rock Hldg Corp (SRRK) | 1.4 | $4.9M | 274k | 17.76 | |
| Integra Lifesciences Holdings Corp Com New (IART) | 1.4 | $4.9M | 137k | 35.45 | |
| Ocular Therapeutix (OCUL) | 1.0 | $3.5M | 383k | 9.10 | |
| Cytomx Therapeutics (CTMX) | 1.0 | $3.5M | 1.6M | 2.18 | |
| Pacira Pharmaceuticals Put Option (PCRX) | 1.0 | $3.3M | 112k | 29.22 | |
| Enanta Pharmaceuticals (ENTA) | 0.9 | $3.1M | 177k | 17.46 | |
| Stoke Therapeutics (STOK) | 0.9 | $3.0M | 226k | 13.50 | |
| Modular Medical Com New (MODD) | 0.8 | $2.8M | 1.5M | 1.85 | |
| Rapt Therapeutics (RAPT) | 0.8 | $2.8M | 315k | 8.98 | |
| Revance Therapeutics (RVNC) | 0.7 | $2.3M | 469k | 4.92 | |
| Ventyx Biosciences (VTYX) | 0.6 | $2.1M | 378k | 5.50 | |
| Boundless Bio (BOLD) | 0.6 | $2.0M | 143k | 14.25 | |
| Aprea Therapeutics Com New (APRE) | 0.6 | $1.9M | 277k | 6.69 | |
| Third Harmonic Bio (THRD) | 0.5 | $1.5M | 163k | 9.44 | |
| Prelude Therapeutics (PRLD) | 0.5 | $1.5M | 320k | 4.74 | |
| Ideaya Biosciences (IDYA) | 0.4 | $1.4M | 33k | 43.88 | |
| Foghorn Therapeutics (FHTX) | 0.2 | $816k | 122k | 6.71 | |
| Nyxoah Sa SHS (NYXH) | 0.2 | $686k | 51k | 13.49 | |
| Vincerx Pharma Com New (VINC) | 0.2 | $516k | 102k | 5.06 | |
| Nextcure (NXTC) | 0.1 | $290k | 130k | 2.23 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $221k | 10k | 21.75 | |
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.0 | $156k | 254k | 0.62 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $110k | 400k | 0.27 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $31k | 50k | 0.62 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $302.268800 | 13k | 0.02 |
